Harpoon Therapeutics
HARP
$23.01
Share price
0.00%
Change (1 day)
3,611.29%
Change (1 year)
Categories
Harpoon Therapeutics (HARP) - Cash on Hand
Cash on Hand as of September 2023 : $31.6 M
According to Harpoon Therapeutics
's latest financial reports the company has $31.6 M in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Harpoon Therapeutics - Cash on Hand chart (from 2017 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $53.11 M | -60.69% |
| 2021-12-31 | $0.13 B | 7.2% |
| 2020-12-31 | $0.12 B | -14.89% |
| 2019-12-31 | $0.14 B | 65.46% |
| 2018-12-31 | $89.49 M | 204.16% |
| 2017-12-31 | $29.42 M | 2887.11% |
| 2016-12-31 | $0.98 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $0.20 B | 558.65% | 🇺🇸 USA |